Tumor mechanism identified

	Tweet

Researchers from the Peninsula Medical School in Plymouth (UK), the Memorial Sloan-Kettering Cancer Center in New York, Cornell University in New York, Weil Medical College in New York and the Center for Neural Tumour Research in Los Angeles, have for the first time identified a key mechanism that makes certain cells become tumorous in the brain. The resulting tumours occur most often spontaneously but can also occur in numbers as part of the inherited disease Neurofibromatosis type 2.

The research is published in the highly respected journal, Cell.

The tumours are caused by mutations affecting a protein called Merlin, which in turn causes cancers in a range of cell types including Schwann cells. Schwann cells produce the sheaths that surround and insulate neurons.

The new research investigates for the first time the role of Merlin in the cell nucleus. It explains how Merlin regulates cell proliferation, and how it regulates gene expression. Normally Merlin inhibits the development of tumours at a cell nucleus level – mutations affecting Merlin affect its ability to inhibit. By understanding this mechanism for the first time, the way is open for the development of effective therapies for a condition in which no treatment other than surgery exists.

In neurofibromatosis 2 the sheer number of the tumours can overwhelm a patient, often leading to severe disability and eventually death. Patients can suffer from 20 to 30 tumours at any one time, and the condition typically affects older children and young adults.

No therapy, other than invasive (radio)surgery aiming at a single tumour and which may not eradicate the full extent of the tumours, exists.

The condition of multiple tumours , neurofibromatosis type two (NF2), affects one in every 2,500 people worldwide. It can affect any family, regardless of past history, through gene mutation and currently there is no cure.

Professor Oliver Hanemann, who led the research from the Peninsula Medical School, commented: “This has been an exciting collaboration with colleagues in the United States resulting in a landmark publication. Until now, there has been no meaningful work on the role of Merlin in the nucleus. The results of our research show a greater understanding of the fundamental part played by Merlin in the repression of tumorous cells, and how this part is undermined when the protein is mutated. Identification of the difference in mechanisms will allow us to develop therapies for the future.”

###

Contact: Andrew Gould

44-139-268-6107
The Peninsula College of Medicine and Dentistry

RELATED STORIES:
Multikine treatment increases survival in cancer patients   Scientists detect cancer genes with new algorithm   How Eating Red Meat Can Spur Cancer Progression   Smart bomb drug zaps cancer cells in mice   Researchers Pinpoint How One Cancer Gene Functions   Mechanism for invasion of tumorous cells discovered by Hebrew University researchers   New method monitors early sign of oxidative stress in cancer   Discovery of a new mechanism of gene control that is associated with cancer   Internet Research Builds Cancer Patients’ Confidence   New Study Begins for Kids With High-Risk Cancer   Cancer patients want info on costly drug options   Considerable Proportion of Patients With Advanced Cancer Undergo Common Cancer Screening   UV light improving chances of fighting cancer   Ludwig Fund gives $120 million for cancer research   Music Therapy Helps Relieve Anxiety of Cancer   How to recognize at an early stage whether a new cancer therapy prolongs life   Study Identifies New Form of Inherited Risk of Cancer   Parents of kids with cancer face traumatic stress   Radionuclide treatment against small tumors and metastases   Messages of Hope Work Better in Motivating Black Patients to Seek Early Screening for Cancer   GW wins US okay for pivotal cannabis drug study   New Hope in Cancer Vaccines Emerges as Novel Therapies are Developed and Tested

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]